Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VDAC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACLY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM98C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOLK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFDP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PREP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C10orf91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C7orf25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PALLD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THBD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAPC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on